Osteoporosis Clinical Trials

Showing 381-400 of 595 trials

COMPLETEDPhase 2

Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)

NCT00533650

A study to asses the safety and efficacy of MK0429 in postmenopausal women with osteoporosis.

Post-Menopausal Osteoporosis

Merck Sharp & Dohme LLC227 participantsStarted Dec 2000

UNKNOWNPhase 4

Effect of Evogliptin on Bone Metabolism in Human

NCT02587975

This study is designed to measure the effect of evogliptin on bone metabolism in healthy volunteers.

Diabetes Mellitus, Type 2Osteoporosis

DongGuk University20 participantsStarted Jun 2016

Goyang-si, Gyeonggi-do, South Korea

COMPLETEDPhase 1

Clinical Study of AK159 in Healthy Postmenopausal Women

NCT01551602

The objective of this study is to investigate the pharmacokinetics, safety, and tolerability of AK159 administered to healthy postmenopausal women.

Osteoporosis

Asahi Kasei Pharma Corporation132 participantsStarted Mar 2012

Fukuoka, Japan • Kumamoto, Japan • Tokyo, Japan

COMPLETEDPhase 3

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

NCT00022087

RATIONALE: Zoledronate plus calcium and vitamin D may prevent bone loss in patients receiving adjuvant chemotherapy for breast cancer. It is not yet known which regimen is more effective in preventing bone loss. PURPOSE: This randomized phase III trial is comparing two regimens of zoledronate plus calcium and vitamin D to see how well they work in preventing bone loss in women who are receiving adjuvant chemotherapy for breast cancer.

Breast CancerOsteoporosis

Alliance for Clinical Trials in Oncology439 participantsStarted Dec 2001

Arroyo Grande, California, United States • La Jolla, California, United States • Mountain View, California, United States +104 more locations

Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)

Effect of Evogliptin on Bone Metabolism in Human

Clinical Study of AK159 in Healthy Postmenopausal Women

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Related Searches

Vitamin D and Calcium Supplement Attenuate Bone Loss Among HIV- Infected Patients Receiving Tenofovir Disoproxil Fumarate, Lamivudine or Emtricitabine and Efavirenz

The Effect of Mechanical Loading on Bone Material Strength and Microarchitecture in Postmenopausal Women

Arteos II Study: Relationship Between Osteoporosis and Arterial Rigidity Within Fractured Patients Cohort

Effects of Jumping on Growing Bones

Bone Mineral Density in HIV+ Patients

Exercise as an Modulator of Immunological Risk Factors for Osteoporosis

A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)

Influence of Osteoporosis on Clinical Outcomes of Mini-invasive Surgical Treatment of Proximal Humerus Fractures

Women's Health Initiative (WHI)

FES-Rowing Versus Zoledronic Acid to Improve Bone Health in Spinal Cord Injury (SCI)

Effect of Thiazolidinediones on Human Bone

Roles of microRNAs in the Development of Osteoporosis in Men - Preliminary Study

A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis

Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients

Fracture and Fall Prevention in Elderly With Osteoporosis

CVD Risk and Health in Postmenopausal Phytoestrogen Users